Two products heading into phase 2 trials, both of which they are going to schedule a pre IND meeting with the FDA. Phase 2 trials will take place in Isreal where the research can get done for pennies on the dollar compared to in the US. An Efficacy study being done on Humans, a big step up from the efficacy study done on biological markers that they completed and announced a 70 percent improvement on. Which in the medical world, is considered a possible breakthrough as they stated.
A MM study ongoing which they are scheduled to start a clinical study on in second half of 2018. This study is designed to head to orphan drug.
1 safety study currently in progress on the cream, and another to start in q2 on our tablet.
Leader ship has changed this summer, with definatley a more qualified team in this field.
I will remain long for the above reasons and more!
News 
Market Data 
Discover 
